CRSP vs. JD
Compare and contrast key facts about CRISPR Therapeutics AG (CRSP) and JD.com, Inc. (JD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CRSP or JD.
Correlation
The correlation between CRSP and JD is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CRSP vs. JD - Performance Comparison
Key characteristics
CRSP:
-0.96
JD:
0.73
CRSP:
-1.52
JD:
1.44
CRSP:
0.84
JD:
1.17
CRSP:
-0.59
JD:
0.52
CRSP:
-1.85
JD:
2.13
CRSP:
26.79%
JD:
18.20%
CRSP:
51.78%
JD:
53.36%
CRSP:
-84.46%
JD:
-79.14%
CRSP:
-84.46%
JD:
-63.19%
Fundamentals
CRSP:
$2.80B
JD:
$60.40B
CRSP:
-$4.34
JD:
$3.70
CRSP:
-0.21
JD:
1.27
CRSP:
$36.12M
JD:
$898.77B
CRSP:
-$32.01M
JD:
$107.27B
CRSP:
-$311.55M
JD:
$40.00B
Returns By Period
In the year-to-date period, CRSP achieves a -17.05% return, which is significantly lower than JD's 6.17% return.
CRSP
-17.05%
-25.52%
-28.04%
-49.82%
-3.69%
N/A
JD
6.17%
-15.88%
-21.63%
40.93%
-0.28%
2.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CRSP vs. JD — Risk-Adjusted Performance Rank
CRSP
JD
CRSP vs. JD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for CRISPR Therapeutics AG (CRSP) and JD.com, Inc. (JD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CRSP vs. JD - Dividend Comparison
Neither CRSP nor JD has paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
CRSP CRISPR Therapeutics AG | 0.00% | 0.00% | 0.00% | 0.00% |
JD JD.com, Inc. | 0.00% | 2.13% | 2.08% | 2.21% |
Drawdowns
CRSP vs. JD - Drawdown Comparison
The maximum CRSP drawdown since its inception was -84.46%, which is greater than JD's maximum drawdown of -79.14%. Use the drawdown chart below to compare losses from any high point for CRSP and JD. For additional features, visit the drawdowns tool.
Volatility
CRSP vs. JD - Volatility Comparison
CRISPR Therapeutics AG (CRSP) has a higher volatility of 15.78% compared to JD.com, Inc. (JD) at 13.91%. This indicates that CRSP's price experiences larger fluctuations and is considered to be riskier than JD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CRSP vs. JD - Financials Comparison
This section allows you to compare key financial metrics between CRISPR Therapeutics AG and JD.com, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities